We are live on
!
Find out more
NPPM
North Point Portfolio Managers Portfolio holdings
AUM
$606M
1-Year Est. Return
20.84%
This Fund
S&P 500
This Quarter
Est. Return
+8.09%
1 Year Est. Return
+20.84%
3 Year Est. Return
+67.16%
5 Year Est. Return
+80.51%
10 Year Est. Return
+331.2%
AUM
$588M
AUM Growth
+$33.9M
(+6.1%)
Cap. Flow
-$4.84M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
36.55%
Holding
73
New
5
Increased
10
Reduced
35
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$11.6M |
| 2 |
Zebra Technologies
ZBRA
|
+$11.4M |
| 3 |
Apple
AAPL
|
+$495K |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$494K |
| 5 |
Corning
GLW
|
+$226K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$6.73M |
| 2 |
ANSS
Ansys
ANSS
|
+$5.36M |
| 3 |
Littelfuse
LFUS
|
+$4.63M |
| 4 |
Danaher
DHR
|
+$3.76M |
| 5 |
ExxonMobil
XOM
|
+$3.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Healthcare | 17.84% |
| 3 | Consumer Discretionary | 14.49% |
| 4 | Financials | 14.34% |
| 5 | Consumer Staples | 11.82% |
Similar funds
SCM
SFCM
BFC
CM
VV
MCM
RCM
V
North Point Portfolio Managers's Q3 2020 Portfolio in Review
As of Q3 2020, North Point Portfolio Managers held 73 positions worth $588M, up 6.1% from $554M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
North Point Portfolio Managers's Q3 2020 filing shows 5 new, 10 increased, 35 reduced and 5 closed positions. Its largest new stake was Chemed: 23,624 shares worth $11.3M. The largest sale was Regeneron Pharmaceuticals, an estimated $6.73M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- North Point Portfolio Managers's largest Q3 2020 buy was Chemed: 23,624 shares worth $11.3M.
- North Point Portfolio Managers added most to Arthur J. Gallagher & Co in Q3 2020, an estimated $494K increase.
- North Point Portfolio Managers's biggest Q3 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $6.73M.
- North Point Portfolio Managers fully exited Littelfuse in Q3 2020, selling an estimated $4.63M.
- North Point Portfolio Managers's ten largest holdings make up 37% of its $588M portfolio in Q3 2020.
- North Point Portfolio Managers opened 5 new positions and closed 5 in Q3 2020.
- North Point Portfolio Managers's portfolio value rose 6.1% quarter-over-quarter to $588M.
Based on North Point Portfolio Managers's 13F filing for Q3 2020, filed 27 Oct 2020.